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Human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) are widely
used in studying basic mechanisms of cardiac arrhythmias that are caused by
ion channelopathies. Unfortunately, the action potential profile of hiPSC-CMs—and
consequently the profile of individual membrane currents active during that action
potential—differs substantially from that of native human cardiomyocytes, largely due
to almost negligible expression of the inward rectifier potassium current (IK1). In the
present study, we attempted to “normalize” the action potential profile of our hiPSC-CMs
by inserting a voltage dependent in silico IK1 into our hiPSC-CMs, using the dynamic
clamp configuration of the patch clamp technique. Recordings were made from single
hiPSC-CMs, using the perforated patch clamp technique at physiological temperature. We
assessed three different models of IK1, with different degrees of inward rectification, and
systematically varied the magnitude of the inserted IK1. Also, we modified the inserted
IK1 in order to assess the effects of loss- and gain-of-function mutations in the KCNJ2
gene, which encodes the Kir2.1 protein that is primarily responsible for the IK1 channel
in human ventricle. For our experiments, we selected spontaneously beating hiPSC-CMs,
with negligible IK1 as demonstrated in separate voltage clamp experiments, which were
paced at 1Hz. Upon addition of in silico IK1 with a peak outward density of 4–6 pA/pF,
these hiPSC-CMs showed a ventricular-like action potential morphology with a stable
resting membrane potential near −80mV and a maximum upstroke velocity >150V/s
(n = 9). Proarrhythmic action potential changes were observed upon injection of both
loss-of-function and gain-of-function IK1, as associated with Andersen–Tawil syndrome
type 1 and short QT syndrome type 3, respectively (n = 6). We conclude that injection
of in silico IK1 makes the hiPSC-CM a more reliable model for investigating mechanisms
underlying cardiac arrhythmias.
Keywords: action potentials, Andersen–Tawil syndrome, cardiac ion channelopathies, inward rectifier potassium
channel, KCNJ2 gene, Kir2.1 protein, patch clamp, short QT syndrome 3
INTRODUCTION
Long QT syndrome (LQTS), with an estimated prevalence of
1:2000 (Schwartz et al., 2009), is the most commonly encoun-
tered inherited arrhythmia disorder in clinical practice (≈35%),
whereas short QT syndrome (SQTS) is the least common one
(≈2%) (Hocini et al., 2014). Both can be related to mutations
in the KCNJ2 gene, which encodes the Kir2.1 member of the
Kir2 protein family. Tetramers of Kir2 proteins constitute the
cardiac inward rectifier potassium channel, which is responsi-
ble for maintaining a stable resting membrane potential in the
working myocardium by conducting the inward rectifier potas-
sium current (IK1) (Dhamoon and Jalife, 2005). IK1 is also largely
responsible for the final repolarization phase of the ventricular
action potential (Shimoni et al., 1992). In human ventricle, Kir2.1
is by far the most abundant Kir2.x protein (92%; Kir2.2: 7%;
Kir2.3:<1%). The same holds true for human atrium, but figures
are somewhat different (81%; Kir2.2: 9%; Kir2.3: 10%), which
may explain the less pronounced rectification of IK1 in human
atrium (Wang et al., 1998).
A loss-of-function mutation in KCNJ2 may result in ven-
tricular arrhythmias and abnormalities on the ECG, including
prolongation of the QT interval. This explains the classification
as LQTS type 7 (LQT7; Tristani-Firouzi et al., 2002). However, the
expression of Kir2.1 channels is not limited to the heart and loss-
of-function mutations in KCNJ2may also lead to periodic paraly-
sis, dysmorphic features and neurocognitive problems. Given the
multisystem nature of the disorder associated with suppression of
Kir2.1 channel function and the only modest QT prolongation, if
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any, Andersen–Tawil syndrome (ATS) has become the preferred
name (Nguyen et al., 2013). With an estimated prevalence in the
order of 1:100,000, ATS is rare. A mutation in KCNJ2 can be
identified in 60–70% of all ATS patients (ATS type 1, ATS1).
Gain-of-function mutations in KCNJ2 are even more rare.
They may cause familial atrial fibrillation type 3 (AF3) as well
as SQTS type 3 (SQT3). The increase in IK1 results in a short-
ening of the repolarization phase of the cardiac action potential
and a predisposition to supraventricular and ventricular arrhyth-
mias (Patel et al., 2010). Only a few SQT3 mutations have been
identified thus far (Priori et al., 2005; Hattori et al., 2012; Deo
et al., 2013; Ambrosini et al., 2014). The E299V (Deo et al., 2013)
and M301K (Hattori et al., 2012) mutations both lead to a largely
abolished rectification of IK1, which explains the shortened action
potential and QT interval.
Unfortunately, the availability of freshly isolated human car-
diomyocytes (CMs) for research is highly limited. This holds for
control myocytes and even more so for myocytes from patients
with channelopathies. Culturing human CMs or mammalian
CMs in general is not an option because these cells lose specific
morphologic and functional properties in culture (Mitcheson
et al., 1998; Louch et al., 2011). For example, there is a significant
decrease in IK1 over time.
Functional aspects of LQTS and related monogenic disor-
ders have been investigated by expressing mutant channels in
heterologous expression systems like Xenopus oocytes, human
embryonic kidney (HEK)-293 cells, and Chinese hamster ovary
(CHO) cells. However, results from expression studies should be
interpreted with care, as illustrated by the essential differences
in results obtained from Xenopus and HEK-293 expression sys-
tems for the 1795insD mutation in SCN5A, encoding the pore
forming subunit of the fast sodium channel (Remme et al.,
2008). Another, highly remarkable illustration comes from the
pathological D1275N mutation in SCN5A, which produces near-
normal currents in multiple heterologous expression experiments
(Watanabe et al., 2011).
The generation of transgenic mice allows the study of mutant
channel behavior in the native myocyte environment. However,
the electrophysiology of murine CMs is essentially different from
that in human, with differences in action potential profile and
underlying membrane currents and, of course, in heart rate, lim-
iting the usefulness of transgenic mouse models for the research
of cardiac ion channelopathies (Nerbonne, 2014).
CMs derived from human induced pluripotent stem cells
(hiPSC-CMs), building on the seminal work of Takahashi et al.
(2007), are a promising new tool in the research of cardiac ion
channelopathies (Zhang et al., 2009; Narsinh et al., 2011). Cell
lines can be disease and species dependent, thus not only allowing
research on the effects of channelopathies in their natural set-
ting, but also on the role of genetic background. Over the past
years, hiPSC-CMs have been used in a growing number of studies
on channelopathies, as reviewed by Hoekstra et al. (2012), Priori
et al. (2013), Sinnecker et al. (2013), Knollmann (2013), Sallam
et al. (2014), Savla et al. (2014), and Shinnawi and Gepstein
(2014).
An essential problem with hiPSC-CMs is their immature phe-
notype. In general, hiPSC-CMs demonstrate spontaneous activity
with a depolarized maximum diastolic potential (MDP), a low
maximum upstroke velocity [(dV/dt)max] and a highly vari-
able action potential duration (Hoekstra et al., 2012). If quies-
cent, their resting membrane potential (RMP) is depolarized in
comparison with that of native working CMs. The depolarized
MDP or RMP of hiPSC-CMs results in inactivation and thus a
lower functional availability of fast sodium channels, which may
explain, at least in part, their low upstroke velocity. Similarly,
functional availability of transient outward potassium channels
may be reduced through inactivation at depolarized potentials
(Cordeiro et al., 2013). Ultrastructurally, there are also differences
between hiPSC-CMs and native CMs. In particular, hiPSC-CMs
exhibit a poorly developed sarcoplasmic reticulum and a lack of
T tubules (Gherghiceanu et al., 2011), which is associated with
immaturity of the Ca2+ homeostasis (Louch et al., 2015).
A common observation in hiPSC-CMs is their virtual lack of
IK1 (Hoekstra et al., 2012), even if the age post-differentiation
is raised to 120 days (Doss et al., 2012), which readily explains
their depolarized MDP or RMP. Several attempts have been
proposed to “mature” hiPSC-CMs through an increase in IK1.
One approach is to mediate the expression of Kir2.1 channels
through adenoviral transduction, as Lieu et al. (2013) demon-
strated for CMs derived from human embryonic stem cells.
Another approach was put forward by Bett et al. (2013). In
their pilot study, they increased IK1 in hiPSC-CMs through “elec-
tronic expression,” using the dynamic clamp technique (Wilders,
2006), and demonstrated that the action potential profile could
be improved by eliminating spontaneous activity and establish-
ing a physiological RMP. Of note, their whole cell patch clamp
experiments were carried out at room temperature and with an
IK1 magnitude that was independent of cell size.
In the present study, we increased the expression level of IK1
in our hiPSC-CMs by adding in silico IK1 using a dynamic patch
clamp approach. We made perforated patch clamp recordings
from a series of hiPSC-CMs at a physiological temperature, sys-
tematically varying the magnitude of IK1 and assessing the effects
of multiple models of IK1, with different degrees of rectification.
Also, we assessed the effects of both loss-of-function and gain-
of-function mutations in IK1 by modifying our in silico IK1, thus
simulating ATS1 and SQT3, respectively.
MATERIALS AND METHODS
CELL PREPARATION
Generation of human induced pluripotent stem cells
Skin punch biopsies were taken from adult healthy volun-
teers, as approved by the ethics committee of the University
Medical Center of the Georg-August-University of Göttingen.
To generate human induced pluripotent stem cells (hiPSCs)
from primary fibroblasts derived from these skin biopsies, the
lentiviral STEMCCA system was used as previously described
(Streckfuss-Bömeke et al., 2013). Briefly, 1.5 × 104 human pri-
mary fibroblasts were plated onto a well of a 12-well plate
1 day prior to the transduction. The viruses were produced
in-house in HEK cells and the supernatant of virus produc-
tions were used. The cells were transduced in fibroblast growth
medium composed of DMEM (Invitrogen) supplemented with
10% heat-inactivated fetal calf serum (FCS, Lonza), L-glutamine
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(2mM, Invitrogen), 1× non-essential amino acids (NEAA,
Invitrogen), β-mercaptoethanol (β-ME, 50μM, Serva), and peni-
cillin (50U/mL)/streptomycin (50μg/mL) at 37◦C with 5% CO2
atmosphere. Additionally, polybrene (2μg/mL, Sigma-Aldrich)
was applied to the medium. After 24 h at 37◦C, the virus particles
were removed by washing the cells three times with DMEM and
the cells were cultured in fibroblast growth medium for another 5
days. The cells were then transferred onto 6-cm cell culture dishes
pre-coated with mitomysin C-inactivated mouse embryonic
fibroblasts (MEFs) at a ratio of 1:4 and the medium was changed
to hES-medium composed of DMEM/F12 (Invitrogen) contain-
ing 20% Knockout serum replacement (Invitrogen), L-glutamine
(2mM), 1× NEAA, β-ME (50μM), and basic fibroblast growth
factor (bFGF, 10 ng/mL, TEBU). The colonies with typical mor-
phology for human pluripotent stem cells first appeared 4–6
weeks later and were mechanically isolated. The isolated hiPSC
colonies were then expanded on MEFs in hES-medium.
Culture of hiPSCs and differentiation to cardiomyocytes
Adherent cultures of hiPSCs were adapted to feeder-free con-
ditions of growth in matrigel-coated dishes, in presence of
chemically defined medium (mTeSR, StemCell Technologies).
Differentiation of hiPSCs to CMs was performed by following
the small molecules-mediated canonical Wnt pathway modula-
tion exactly as previously described (Lian et al., 2013). Briefly,
undifferentiated adherent cultures were treated with CHIR99021
(12μM, Selleckchem) for 24 h on day 1, followed byWnt pathway
inhibition by IWP4 (5μM, Stemgent) on day 4 and 5 of differ-
entiation. After culturing for 7 days in RPMI medium with B27
(Invitrogen/Life Technologies), insulin was added and differenti-
ating cells were cultured until day 30. Enrichment for CMs was
performed by adding 4mM lactic acid in substitution of glucose
(Tohyama et al., 2013) for 6 days.
Dissociation of cardiomyocytes
Single hiPSC-CMs were obtained by enzymatic dissociation fol-
lowing a protocol somewhat similar to one previously described
for the isolation of rabbit sinoatrial nodal cells (Verkerk et al.,
2009). The cardiomyocyte-enriched cultures were transferred
manually to a low-Ca2+ Tyrode solution, containing (in mM):
140 NaCl, 5.4 KCl, 0.01 CaCl2, 1.0 MgCl2, 5.5 glucose, 5.0
HEPES, and 14.1 creatine; pH 7.4 (NaOH). After an incubation
of 10min at room temperature, Liberase (0.04mg/mL, Roche
Chemicals) and Elastase (0.01mg/mL, Serva) were added and
cells were incubated for 10min at 37◦C while shaking gently.
Subsequently, supernatant was removed and a Kraft–Brühe solu-
tion (37◦C) was added to stop the enzymatic dissociation. This
Kraft–Brühe solution contained (in mM): 85 KCl, 30 K2HPO4,
5.0 MgSO4, 5.5 glucose, 5.0 pyruvic acid, 5.0 creatine, 30 tau-
rine, 5.0 Na-hydroxybutyric acid, 5.0 succinic acid, 2.0 Na2ATP
and 1% BSA; pH 7.2 (KOH). Dissociation to single cells was
achieved by a short period of firm manual shaking, after which
the cell suspensions were incubated at 37◦C for 10min while
shaking. hiPSC-CMs were centrifuged and resuspended in basic
differentiation medium, i.e. RPMI medium supplemented with
B27, to which 20% FBS and penicillin (50U/mL)/streptomycin
(50μg/mL) were added, and plated on 0.1% gelatin-coated glass
coverslips. Medium was replaced with serum-free medium after
24 h and subsequently with antibiotic-free medium every 3–4
days. Electrophysiological analysis was performed 10–15 days
after dissociation.
ELECTROPHYSIOLOGY
Electrophysiological recordings
Electrophysiological recordings were made from single sponta-
neously active hiPSC-CMs through the amphotericin-B perfo-
rated patch clamp technique, using an Axopatch 200B amplifier
(Molecular Devices, Sunnyvale, CA). Cells selected for experi-
ments showed spontaneous beating upon visual inspection. The
cell chamber was put on the stage of a Nikon Eclipse TE2000-U
inverted phase-contrast microscope. Cells were superfused with
the above Tyrode solution with 1.8mM CaCl2 and without crea-
tine. Low-resistance borosilicate glass pipettes (1.5–2.5 M) were
filled with a solution containing (in mM): 125 K-gluconate, 20
KCl, 5 NaCl, 10 HEPES, and 0.44 amphotericin-B; pH 7.2 (KOH).
Series resistance was compensated by ≥ 80% and potentials were
corrected for the estimated liquid junction potential of −15mV.
Voltage control, data acquisition, and data analysis were
accomplished using custom-written software running on an
Apple Macintosh G4 computer equipped with a National
Instruments NB-MIO-16 twelve-bit data acquisition board.
Action potentials were low-pass filtered (5 kHz) and digitized at
4 kHz. Membrane currents were filtered and digitized at 2 and
5 kHz, respectively. Cell membrane capacitance was estimated by
dividing the time constant of the decay of the capacitive tran-
sient in response to 5mV hyperpolarizing voltage clamp steps
from −40mV by the series resistance, and amounted to 25 ± 4
pF (mean ± SEM, n = 9). All experiments were carried out at a
temperature of 35–37◦C.
We analyzed various action potential characteristics, including
maximum diastolic potential (MDP), action potential ampli-
tude (APA), maximal upstroke velocity [(dV/dt)max], and action
potential duration at 90% repolarization (APD90). Action poten-
tial parameters from 10 consecutive action potentials were
averaged.
Voltage clamp recordings of IK1
In a separate series of experiments, the amplitude of the intrin-
sic IK1 of hiPSC-CMs was assessed using the voltage clamp mode
of the whole cell patch clamp configuration, using the aforemen-
tioned setup. As before, selected cells were beating upon visual
inspection. IK1 was recorded as a barium sensitive current. First,
5μM nifedipine was washed in to block Ca2+ channels, thus pre-
venting contaminating effects of Ba2+ on calcium currents. Next,
1mM BaCl2 was washed in to block inward rectifier channels
(Schram et al., 2003). The barium sensitive current was deter-
mined by subtracting the current traces recorded in the presence
of both nifedipine and Ba2+ from those recorded in the presence
of nifedipine. The applied voltage clamp protocol consisted of a
series of 100ms steps from a holding potential of −80mV to a
test potential of −100mV. IK1 was defined as the difference cur-
rent at the end of the 100ms step and was normalized for cell size
through the membrane capacitance, which amounted to 33 ± 7
pF (mean ± SEM, n = 7).
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Dynamic clamp
To supply a hiPSC-CM with a controllable virtual IK1, we used
the dynamic clamp technique (Wilders, 2006). As diagrammed in
Figure 1, the membrane potential Vm of the hiPSC-CM, which
is recorded using the perforated patch clamp technique in cur-
rent clampmode, is continuously sampled into a Real-Time Linux
(RT-Linux) based personal computer. The Vm-dependent current
IK1 is computed and a command potential generated that, com-
bined with a command potential for any stimulus current Istim,
is sent to the patch clamp amplifier to inject this current into the
hiPSC-CM. The virtual IK1 is updated at a rate of 25 kHz and both
Vm and the injected current Iin are stored at a rate of 4 kHz on
the standard Apple Macintosh G4 laboratory computer for offline
analysis using custom software.
Three types of wild-type (WT) IK1 models were used: “Kir2.1”
based on a fit to data from Kir2.1 channels expressed in HEK-293
cells by Dhamoon et al. (2004), “TNNP” as used in the human
ventricular cell model by ten Tusscher et al. (2004), and “Bett”
as used by Bett et al. (2013) in their “electronic expression” of
IK1 in hiPSC-CMs. The current-voltage relationships of these IK1
models, all scaled to a peak outward current density of 1 pA/pF,
are shown in Figure 2A.
The mathematical equation for the “Kir2.1” current-voltage
relationship of Figure 2A reads:
IK1 = 0.12979 ×
(
Vm − EK
1.0 + e(0.093633×(Vm+72))
)
In this equation, in which the rectification properties of IK1 are
implemented through a Boltzmann equation, IK1 is in pA/pF and
Vm is inmV. EK is the Nernst potential for potassium, which
amounts to −86.9mV in our experimental setting.
FIGURE 1 | Diagram of the experimental setup. The membrane potential
(Vm) of a single human induced pluripotent stem cell derived cardiomyocyte
(hiPSC-CM) is recorded using the perforated patch clamp technique in
current clamp mode. The injected current (Iin) is the sum of a stimulus
current (Istim) and a virtual inward rectifier potassium current (IK1), which is
computed in real time, based on the recorded value of Vm (dynamic clamp).
The stimulus protocol is run on an Apple Macintosh G4 computer (left),
whereas a Real-Time Linux (RT-Linux) based PC is used for the continuous
computation of IK1 (right). Sample rates are 4 and 25 kHz, respectively
(t1 = 0.25 ms and t2 = 40 μs).
The equation for the “TNNP” current-voltage relationship of
Figure 2A reads:
IK1 = 0.54419 × GK1 ×
√
Ko
5.4
×xK1∞ × (Vm − EK)
This is the equation for IK1 taken from the ten Tusscher et al.
(2004) human ventricular cell model with a scaling factor of
0.54419 to arrive at a peak outward current density of 1 pA/pF.
GK1 denotes the maximal IK1 conductance of 5.405 nS/pF and Ko
is the extracellular K+ concentration of 5.4mM, whereas xK1∞ is
FIGURE 2 | Current-voltage relationship of inward rectifier potassium
current (IK1) added to human induced pluripotent stem cell derived
cardiomyocytes (hiPSC-CMs) through dynamic clamp. (A) IK1 based on
data from Kir2.1 channels expressed in HEK-293 cells by Dhamoon et al.
(2004) (“Kir2.1,” blue line), IK1 from the human ventricular cell model by ten
Tusscher et al. (2004) (“TNNP,” red line), and the synthetic IK1 used by Bett
et al. (2013) (“Bett,” green line). Peak outward amplitude scaled to 1 pA/pF.
(B) Current-voltage relationships for loss-of-function and gain-of-function
mutations in Kir2.1, encoded by the KCNJ2 gene. The orange line
(“gain-of-function”) represents the heterozygous E299V mutation in KCNJ2
studied by Deo et al. (2013), whereas the magenta line (“loss-of-function”)
represents a dominant-negative mutation resulting in a decrease in
amplitude to 10% of the wild-type Kir2.1 current of panel (A) (blue line).
Note difference in ordinate scale between panels (A) and (B).
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defined through:
xK1∞ = αK1
αK1 + βK1
αK1 = 0.1
1 + e0.06(Vm−EK−200)
βK1 = 3e
0.0002(Vm−EK+100) + e0.1(Vm−EK−10)
1 + e−0.5(Vm−EK )
The equation for the “Bett” current-voltage relationship of
Figure 2A reads:
IK1 = 0.587557 × ( 0.5 ×
(
Vm − EK
1 + e(0.0896(Vm− EK ))
)
+ 0.01 ×
(Vm − EK) )
In the original equation of Bett et al. (2013), EK was set to−85mV
and a potentiometer was used to generate a standard IK1 ampli-
tude of 150 pA at −75mV, independent of cell size. Here, we
used the equation of Bett et al. (2013) with the computed EK
of −86.9mV and a scaling factor of 0.587557 to arrive at a peak
outward current density of 1 pA/pF. In contrast with the above
“Kir2.1” and “TNNP” equations, the “Bett” equation contains
a linear part, which explains the shape of the current-voltage
relationship at membrane potentials > −20mV, for which the
non-linear part approaches zero.
Another two IK1 models were used to simulate loss-of-function
and gain-of-function mutations in the Kir2.1 encoding KCNJ2
gene. A dominant-negative mutation resulting in a reduction
in IK1 to 10% of wild-type control was used to simulate com-
monly observed functional effects of mutations associated with
Andersen–Tawil syndrome type 1 (Nguyen et al., 2013), whereas a
heterozygous gain-of-function mutation was based on the E299V
mutation in KCNJ2 that is associated with short QT syndrome
type 3. Comprehensive data on this mutation were obtained by
Deo et al. (2013).
The dominant-negative mutation in KCNJ2 was simulated by
scaling the above wild-type Kir2.1 based IK1 by a factor of 0.1,
thus arriving at:
IK1 = 0.012979 ×
(
Vm − EK
1.0 + e(0.093633×(Vm + 72))
)
This equation results in the “loss-of-function” current-voltage
(I–V) relationship of Figure 2B (magenta line). The “gain-of-
function” I–V relationship (Figure 2B, orange line) was obtained
by fitting a “Kir2.1”-like equation to the data of Deo et al. (2013),
which resulted in:
IK1 = 0.98765 ×
(
Vm − EK
1.0 + e(0.020133(Vm + 170.26))
)
The scaling factor of 0.98765 followed from the amplitude of the
heterozygous mutant Kir2.1 current relative to wild-type Kir2.1
current reported by Deo et al. (2013).
In our dynamic clamp experiments, the hiPSC-CMs were
stimulated at 1Hz using 3-ms stimuli that ranged from 200 to
800 pA in amplitude. A virtual IK1, defined by any of the above
equations, was added using the setup of Figure 1. The peak out-
ward amplitude of this IK1 was varied between 0 and 10 pA/pF in
steps of 1 or 2 pA/pF. To minimize any time effects, the order of
application of IK1 models was varied between experiments.
STATISTICS
Data are presented as mean± SEM. Two-Way Repeated Measures
ANOVA followed by the Holm–Sidak post-hoc test was used for
comparing the different IK1 models and different IK1 amplitudes.
An unpaired t-test with Bonferroni correction for multiple com-
parisons was used to compare action potential parameters of
hiPSC-CMs and human ventricular myocytes. Statistical analy-
sis was carried out with SigmaStat 3.5 software. P < 0.05 was
considered statistically significant.
RESULTS
CHARACTERISTICS OF hiPSC-CMs
Figure 3 illustrates the morphological and electrophysiological
phenotype of our hiPSC-CMs in comparison with that of native
human ventricular myocytes (VMs). For these human VMs we
used data that we obtained in the course of a previous study
(Verkerk et al., 2005).
Whereas native human VMs are elongated and show a clear
and regular cross-striated pattern (Figure 3A, left), the hiPSC-
CMs are relatively small and less well-organized (Figure 3A,
right). In the same dish, their appearance can be circular, with
a diameter of ≈10μm, as well as somewhat elongated.
When we made current clamp recordings from our hiPSC-
CMs using the perforated patch clamp technique, we obtained
widely different action potentials (Figures 3B,C). Some cells
were visually beating and showed spontaneous electrical activ-
ity (Figure 3B). Others were intrinsically quiescent and action
potentials could be elicited with 3ms rectangular stimulus pulses
of typically 400–600 pA. With a value of ≈ −50mV their rest-
ing membrane potential was clearly depolarized compared to that
of freshly isolated native VMs (Figure 3C, solid lines vs. dashed
line). Also, the action potential duration was considerably shorter,
even if we take into consideration that our native VMs originate
from explanted hearts of patients with end-stage heart failure and
thus most likely show a prolonged action potential due to down-
regulation of repolarizing currents (Tomaselli andMarbán, 1999),
including IK1 (Beuckelmann et al., 1993).
Figure 3D shows action potential parameters of 9 spon-
taneously beating hiPSC-CMs (left black bars) as well as 9
native human VMs (right green bars). As already apparent from
Figures 3B,C the action potential amplitude (APA) of 73 ± 9mV
of the hiPSC-CMs is smaller than that of native human VMs and
the action potential duration at 90% repolarization (APD90) of
162 ± 27ms is shorter (Figure 3D, right). Also, the (dV/dt)max of
10 ± 7V/s is much smaller, but this may, at least partly, be due to
the depolarized MDP of −56 ± 4mV (Figure 3D, left), because
such depolarization may result in almost totally inactivated fast
sodium channels and thereby in a strongly reduced (dV/dt)max
(Berecki et al., 2010).
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FIGURE 3 | Morphological and electrophysiological phenotype of human
induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) and
native human ventricular myocytes (VMs). (A) Phase-contrast micrographs
of a typical human VM (left) and four hiPSC-CMs (right). Differently shaped
hiPSC-CMs were present at close distance in the same microscope field. (B)
Action potentials of three different spontaneously active hiPSC-CMs. (C)
Action potentials of three different intrinsically quiescent hiPSC-CMs upon 1
Hz stimulation (solid lines) and a typical action potential of a single human VM
isolated from a failing heart upon 1 Hz stimulation (dashed line). (D)
Maximum diastolic potential (MDP), maximum upstroke velocity [(dV/dt)max],
action potential amplitude (APA) and action potential duration at 90%
repolarization (APD90) of 9 hiPSC-CMs (left bars) and 9 human VMs (right
bars), all stimulated at 1Hz. Human VMs were isolated from explanted hearts
of male patients in end-stage heart failure (Verkerk et al., 2005), ∗P < 0.05.
AMPLITUDE OF NATIVE IK1
Because we hypothesized that the depolarized MDP of our
hiPSC-CMs was caused by a lack of IK1, we carried out volt-
age clamp experiments to determine the amplitude of IK1. In
5 out of 7 cells studied, a detectable IK1 was absent. The
remaining two cells showed a small IK1 with an amplitude
of 0.36 ± 0.14 pA/pF at −100mV. To allow for a compar-
ison with the amplitude of the native IK1 in isolated mam-
malian VMs, we carried out a literature search. Results of this
search are presented in Figure 4. Results of this search are pre-
sented in Figure 4, based on data of Beuckelmann et al. (1993),
Liu et al. (1993), Konarzewska et al. (1995), Koumi et al.
(1995a,b,c), Kääb et al. (1996), Rozanski et al. (1997), Bailly et al.
(1998), Li et al. (1998), Wang et al. (1998), Zaza et al. (1998),
Mitcheson and Hancox (1999), Schaffer et al. (1999), Magyar
et al. (2000), Pacher et al. (2000), Ishihara et al. (2002), Xiao
et al. (2006), Bányász et al. (2007), Jost et al. (2009), Banyasz
et al. (2011), Ma et al. (2011), Doss et al. (2012), and Nagy et al.
(2013).
According to data from literature, there are large variations in
the amplitude of IK1. If measured at −100mV, this amplitude
is typically ≈10 pA/pF, more or less independent of the consid-
ered species (guinea pig, rabbit, dog and human) (Figure 4A).
However, canine data vary between 8.9 ± 1.2 and 43.2 ± 1.6
pA/pF (n = 5 and n = 43, respectively) and human data between
3.6 ± 1.4 and 32.1 ± 1.7 pA/pF (n = 4 and n = 14, respectively).
Nevertheless, with the above 0.36 ± 0.14 pA/pF and values of
0.8 ± 0.2 (n = 6; Ma et al., 2011) and 2.2 ± 0.4 pA/pF (n = 38;
Doss et al., 2012), the amplitude in hiPSC-CMs is considerably
smaller than generally observed in human VMs.
In terms of functional relevance, the amplitude of the peak
outward IK1 (labeled “B” in Figure 4A, inset) is more rele-
vant than that at −100mV, which is outside the physiological
membrane potential range. However, data on this peak outward
current are relatively scarce. As shown in Figure 4B, this peak out-
ward amplitude is typically reached at ≈ −65mV and amounts
to ≈2 pA/pF, again more or less independent of species. Human
data vary between 0.57 ± 0.15 (n = 8; Bailly et al., 1998) and
2.2 ± 0.35 pA/pF (n = 6; Wang et al., 1998). Data on peak out-
ward IK1 in hiPSC-CMs are limited to a peak value of 1.0 ± 0.2
pA/pF (n = 6; Ma et al., 2011), which was observed at a mem-
brane potential of −35mV rather than ≈ −65mV and is not
shown in Figure 4B.
Another discrepancy between studies on IK1 in mammalian
VMs is in the shape of the I-V relationship. In some studies,
it is reported that IK1 approaches zero at potentials > −20mV,
whereas a substantial current is reported in others, as illus-
trated by the solid and dashed lines in the inset to Figure 4A. In
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FIGURE 4 | Amplitude of inward rectifier potassium current (IK1) in
mammalian ventricular myocytes and human induced pluripotent
stem cell derived cardiomyocytes (hiPSC-CMs). (A) Amplitude of IK1 at a
membrane potential of −100 mV. Note axis break. (B) Amplitude of peak
outward IK1. Inset illustrates current-voltage relationship of IK1 with values
shown in panels A and B. Data are mean ± SEM obtained at room
temperature (bars labeled “RT”) or at physiological or close-to-physiological
temperature. If data are available, numbers in gray above bars in (B)
indicate the membrane potential (in mV) at which the peak outward
amplitude is reached, whereas dark blue triangles indicate the approximate
amplitude at 0 mV. Some data are estimated from graphs.
Figure 4B, the amplitude of IK1 at 0mV is indicated by dark blue
triangles. It varies between 0 and 25% of the peak outward ampli-
tude. In the “Kir2.1,” “TNNP,” and “Bett” models for IK1, this is
1, 1, and 52%, respectively (see Figure 2A).
ADDITION OF IK1 THROUGH DYNAMIC CLAMP
Knowing that the native IK1 of our hiPSC-CMs is very small in
comparison with that in human VMs (Figure 4), we decided to
supply our hiPSC-CMs with an “IK1 boost” through dynamic
clamp, injecting a current through the patch clamp pipette with
the functional characteristics of the lacking IK1, as set out in
Materials andMethods Section Dynamic Clamp and diagrammed
in Figure 1. Given the uncertainty regarding the “normal” ampli-
tude of IK1 in human VMs as well as the shape of its I–V
relationship, we selected three different models of IK1 and varied
the amplitude over a wide range.
We injected an in silico IK1 into nine different hiPSC-CMs and
assessed the effects on the action potential. For each hiPSC-CM,
we used each of the “Kir2.1,” “TNNP,” and “Bett” models for IK1,
with characteristics detailed in Materials and Methods Section
Dynamic Clamp and illustrated in Figure 2. Of note, the I–V rela-
tionship of the Kir2.1 and TNNP models is similar to that shown
as a solid line in the inset to Figure 4A. In this respect, the Bett
model is different, with a substantial current in the membrane
potential range of the action potential plateau (Figure 2).
The amplitude of the injected IK1 was scaled according to its
peak outward current density, which was set to values of 0 (no
IK1 injected), 1, 2, 4, 6, 8, or 10 pA/pF. Thus, the three differ-
ent IK1 models could be readily compared in the physiological
membrane potential range. It should be noted, however, that an
identical peak outward current density does not imply an iden-
tical amplitude at −100mV. If, for example, the peak outward
current density was set 2 pA/pF, this IK1 amplitude at −100mV
amounted to 3.2, 73.7, and 6.0 pA/pF for the Kir2.1, TNNP, and
Bett models, respectively.
Injection of “Kir2.1” IK1
Figure 5A shows the native action potential of a hiPSC-CM stim-
ulated at a frequency of 1Hz (black trace) and its action potential
upon injection of a Kir2.1 IK1 with a peak outward density of
1–10 pA/pF. The corresponding injected current is shown in
Figure 5B. With an IK1 of 1 pA/pF peak amplitude, the mem-
brane potential becomes hyperpolarized by ≈7 to −72mV, but
the spontaneous diastolic depolarization of the cell is not fully
suppressed. Doubling the peak amplitude of the injected IK1 to 2
pA/pF results in a stable RMP of −79mV (Figure 5A, blue trace).
At this potential, the injected current is ≈ −50 pA (Figure 5B,
blue trace), which has the functional effect of an outward, positive
membrane current of 50 pA. Accordingly, the negative injected
current is depicted as an upward deflection.
Upon further increasing the peak outward density of IK1
to 4–10 pA/pF, the RMP becomes more negative, reaching an
almost steady value near −84mV, at which the simulated IK1
amounts to ≈70 pA (Figures 5A,B). The increase in peak current
(Figure 5B) causes a more pronounced final repolarization phase
of the action potential as well as a shortening in action poten-
tial duration (Figure 5A). Also, both (dV/dt)max and APA tend to
increase, but this is not immediately apparent from Figure 5A.
A statistically significant difference with respect to control
(zero IK1 addition) is found for the MDP, (dV/dt)max and
APA starting at a peak outward IK1 amplitude of 4 pA/pF
(Figures 5C–E). Significant differences in MDP, (dV/dt)max and
APA are also found between 1 or 2 pA/pF IK1 and higher ampli-
tudes (Figures 5C–E). Injection of IK1 with a peak outward
density of 4 pA/pF results in an average RMP of −78.0 ± 1.3mV.
For the same IK1 amplitude, a value of 146 ± 35V/s is found
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FIGURE 5 | Effect of Kir2.1-based IK1 on the action potential of
hiPSC-CMs. (A) Action potential of a hiPSC-CM upon injection of simulated
IK1, which is computed in real time according to the “Kir2.1” current-voltage
relationship of Figure 2A with its peak outward amplitude scaled to 0–10
pA/pF, as indicated. (B) Corresponding dynamic clamp current injected into
the cell. The sharp peak at time 25 ms is due to the stimulus current of 3 ms
duration and 600 pA amplitude. (C–F) Maximum diastolic potential (MDP),
maximum upstroke velocity [(dV/dt)max], action potential amplitude (APA) and
action potential duration at 90% repolarization (APD90) of 9 hiPSC-CMs at IK1
peak outward amplitudes of 0–10 pA/pF, ∗P < 0.05.
for (dV/dt)max. In line with Figure 5A, Figures 5C,D may sug-
gest a further hyperpolarization of the MDP and an increase
in (dV/dt)max with increasing peak outward density of IK1, but
differences were not statistically significant. Figure 5F shows a
negative trend in APD90, from 202 ± 22ms at 2 pA/pF to 131 ±
24ms at 10 pA/pF, but only the APD90 values at 2 and 10 pA/pF
are statistically significantly different.
Injection of “TNNP” IK1
Highly similar results were obtained with the TNNP model
of IK1, which comes from the widely used ten Tusscher et al.
(2004) model of a human ventricular cell. The outward peak
is reached at a slightly less negative membrane potential than
with the Kir2.1 model (−66.1 vs. −68.5mV; Figure 2), but
otherwise the I–V relationships are largely comparable within
the physiological membrane potential range, positive to EK.
Figure 6A shows the effects of injection of the TNNP IK1
on the action potential of the same hiPSC-CM as used for
Figure 5A. The corresponding injected current is shown in
Figure 6B. With an IK1 of 1 pA/pF peak amplitude, the mem-
brane potential now becomes hyperpolarized by ≈6 to −71mV.
Again, the spontaneous diastolic depolarization is not fully
suppressed. A stable RMP of −77mV is achieved upon dou-
bling the peak amplitude of the injected IK1 to 2 pA/pF
(Figure 6A, blue trace). One may speculate that the slightly
smaller hyperpolarization than with the Kir2.1 IK1 (−71 vs.
−72mV and −77 vs. −79mV) reflects the slightly smaller
amplitude of the TNNP IK1 in this membrane potential range
(Figure 2A).
Further observations are highly similar to those with the Kir2.1
IK1 model. A stable RMP near −84mV is reached upon further
increasing the peak outward density of IK1 to 4–10 pA/pF and the
increase in peak current causes a more pronounced final repo-
larization phase of the action potential as well as a shortening
in action potential duration (Figures 6A,B). Also, an increase in
(dV/dt)max and APA is observed.
For both MDP and APA, a statistically significant difference
with respect to control (zero IK1 addition) occurs at peak out-
ward IK1 amplitudes of 2 pA/pF and higher (Figures 6C,E). For
(dV/dt)max, statistical significance is reached at 4 pA/pF and
higher (Figure 6D). Significant differences in MDP, (dV/dt)max
and APA are also found between 1 or 2 pA/pF IK1 and higher
amplitudes (Figures 6C–E). Injection of IK1 with a peak out-
ward density of 4 pA/pF results in an average RMP of −78.3 ±
1.2mV. For the same IK1 amplitude, a value of 149 ± 33V/s
is found for (dV/dt)max. More hyperpolarized values for MDP
and higher values for (dV/dt)max are observed at 6–10 pA/pF,
but differences are not statistically significant. As with the Kir2.1
IK1, a negative trend in APD90 is observed (Figure 6F), from
208 ± 20ms at 2 pA/pF to 162 ± 29ms at 10 pA/pF, but it
is less pronounced and no statistically significant differences are
obtained.
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FIGURE 6 | Effect of TNNP-based IK1 on the action potential of
hiPSC-CMs. (A) Action potential of a hiPSC-CM upon injection of simulated
IK1, which is computed in real time according to the “TNNP” current-voltage
relationship of Figure 2A with its peak outward amplitude scaled to 0–10
pA/pF, as indicated. (B) Corresponding dynamic clamp current injected into
the cell. The sharp peak at time 25 ms is due to the stimulus current of 3 ms
duration and 600 pA amplitude. (C–F) Maximum diastolic potential (MDP),
maximum upstroke velocity [(dV/dt)max], action potential amplitude (APA) and
action potential duration at 90% repolarization (APD90) of 9 hiPSC-CMs at IK1
peak outward amplitudes of 0–10 pA/pF, ∗P < 0.05.
Injection of “Bett” IK1
With the Bett model of IK1, we obtained different results. This
is because of the substantial current at less negative membrane
potentials, which is in contrast with the Kir2.1 and TNNP
models of IK1 (Figure 2A). Figure 7A shows the effects of injec-
tion of Bett IK1 on the action potential of the same hiPSC-CM
as used for Figures 5A, 6A. The corresponding injected cur-
rent is shown in Figure 7B. The injected current shows a clear
non-zero component directly after the stimulus current, which
lasts throughout the plateau phase of the action potential and
results in a relatively short action potential, due to an early
start of repolarization (Figures 7A,B). With an IK1 of 1 pA/pF
peak amplitude, themembrane potential becomes hyperpolarized
to−73mV and this time the spontaneous diastolic depolarization
is completely suppressed. Upon doubling the peak amplitude of
the injected IK1 to 2 pA/pF, a stable RMP of −80mV is observed
(Figure 7A, blue trace). The early suppression of spontaneous
activity and slightly larger hyperpolarization may be attributed to
the larger IK1 at membrane potentials negative to −70mV than
with the Kir2.1 and TNNP models of IK1 (Figure 2A).
As with the Kir2.1 and TNNP models of IK1, a statistically
significant difference with respect to control (zero IK1 addition)
is found for the MDP, (dV/dt)max and APA starting at a peak
outward IK1 density of 4 pA/pF (Figures 7C–E). Significant dif-
ferences in MDP, (dV/dt)max and APA are also found between 1
or 2 pA/pF IK1 and higher amplitudes (Figures 7C–E). Injection
of IK1 with a peak outward density of 4 pA/pF results in an aver-
age RMP of −79.6 ± 1.2mV and an average (dV/dt)max of 163 ±
36V/s. Slightly more hyperpolarized values for MDP and higher
values for (dV/dt)max are observed at 6–10 pA/pF, but differ-
ences are not statistically significant. As already apparent from
Figures 7A,B, the substantial plateau IK1 results in pronounced
action potential shortening. In particular, APD90 decreases from
160 ± 22ms at 4 pA/pF to 99 ± 24ms at 10 pA/pF. However,
it should be noted that only the APD90 at 10 pA/pF differs sta-
tistically significantly from the APD90 at some of the lower IK1
densities (Figure 7F).
Comparison of IK1 models
In Figure 8 the results obtained with the three different mod-
els for IK1 are compared, thus concretizing differences between
the three models. The typical effects on the action potential of
the Kir2.1 and TNNP IK1 models, obtained with an IK1 peak
amplitude of 6 pA/pF and another hiPSC-CM than in the typical
examples of Figures 5–7, are highly similar, but the Bett IK1 model
causes a shorter action potential (Figure 8A). This shorter action
potential is in line with the injected current, which shows a sub-
stantial Bett IK1 during the early repolarization phase and plateau
phase of the action potential (Figure 8B). The average APD90 at
an IK1 peak amplitude of 6 pA/pF amounts to 129 ± 24ms for
the Bett model vs. 162 ± 18 and 171 ± 25ms for the Kir2.1 and
TNNP IK1 models, respectively (Figure 8F). A similar pattern is
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FIGURE 7 | Effect of Bett-based IK1 on the action potential of hiPSC-CMs.
(A) Action potential of a hiPSC-CM upon injection of simulated IK1, which is
computed in real time according to the “Bett” current-voltage relationship of
Figure 2A with its peak outward amplitude scaled to 0–10 pA/pF, as
indicated. (B) Corresponding dynamic clamp current injected into the cell.
The sharp peak at time 25 ms is due to the stimulus current of 3 ms duration
and 600 pA amplitude. (C–F) Maximum diastolic potential (MDP), maximum
upstroke velocity [(dV/dt)max], action potential amplitude (APA) and action
potential duration at 90% repolarization (APD90) of 9 hiPSC-CMs at IK1 peak
outward amplitudes of 0–10 pA/pF, ∗P < 0.05.
seen at other IK1 peak amplitudes in the 2–10 pA/pF range. Yet,
statistically significant differences in APD90 are mainly observed
between the TNNP and Bett IK1 models (Figure 8F).
MDP and APA values are highly similar between the
three IK1 models, except for statistically significant differences
found at the lower IK1 peak amplitudes of 1 and 2 pA/pF
(Figures 8C,E). BothMDP and APA seem to “saturate,” at≈ −80
and ≈120mV, respectively, for the higher amplitudes of 4–10
pA/pF. Such saturation is somewhat less apparent for (dV/dt)max
(Figure 8D), but it reaches typical values of 160–200V/s for
each of the models. One may argue that the statistically signif-
icant difference in (dV/dt)max at 10 pA/pF reflects the shorter
APD90 with the Bett model, which results in a longer inter-
val for recovery of sodium channels between consecutive action
potentials.
FUNCTIONAL EFFECTS OF IK1 CHANNELOPATHIES
To explore possible applications of our technique, we assessed
both loss-of-function and gain-of-function mutations in Kir2.1,
which is encoded by the KCNJ2 gene and is the primary compo-
nent of the ventricular IK1 channel. To simulate a loss-of-function
mutation we reduced the wild-type Kir2.1 based IK1 to 10% of
control, in line with the functional effects that are commonly
observed in case of heterozygous dominant-negative mutations
in KCNJ2 associated with the Andersen–Tawil syndrome (type 1;
ATS1). As a gain-of-functionmutation we chose the heterozygous
E299V mutation, which is associated with the short QT syn-
drome (type 3; SQT3). The corresponding I–V relationships are
shown in Figure 2B, in comparison with the wild-type relation-
ship. Experiments were carried out in a total of 6 hiPSC-CMs and
the peak amplitude of the wild-type Kir2.1 was varied over the
same 0–10 pA/pF as before. Figures 9A,B show a typical example
at a wild-type peak amplitude of 6 pA/pF and Figures 9C–F show
the average action potential parameters of the 6 hiPSC-CMs. Note
that the 0–10 pA/pF IK1 peak amplitude values in Figures 9C–F
are those for the wild-type case. The corresponding peak ampli-
tudes are 0–1 pA/pF (10% of control) and 0–31.6 pA/pF for the
loss-of-function and gain-of-function mutations, respectively, in
line with the I–V relationships of Figure 2B.
Simulation of the gain-of-function mutation results in injec-
tion of an IK1 with such a large amplitude immediately following
the action potential upstroke that the action potential is dramati-
cally shortened (Figures 9A,B, orange traces). Such shortening is
not limited to the IK1 density of 6 pA/pF in Figures 9A,B. A sta-
tistically significant decrease relative to wild-type Kir2.1 occurs
at each of the IK1 densities >1 pA/pF (Figure 9F, right orange
bars vs. left blue bars). No statistically significant differences vs.
wild-type are observed in (dV/dt)max and APA (Figures 9D,E),
but RMP is more hyperpolarized, with full suppression of spon-
taneous depolarization, at 1 and 2 pA/pF (Figure 9C).
Although not statistically significant, the gain-of-function
(dV/dt)max seems to become lower than the wild-type (dV/dt)max
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FIGURE 8 | Dynamic clamp with different IK1 models. (A) Control action
potential of a hiPSC-CM (black trace) and action potential of this cell upon
injection of IK1 computed in real time according to the “Kir2.1,” “TNNP,” or
“Bett” IK1 models of Figure 2A (blue, red, and green lines, respectively), all
with a peak outward amplitude of 6 pA/pF. (B) Corresponding dynamic clamp
current injected into the cell. The sharp peak at time 25 ms is due to the
stimulus current of 3 ms duration and 600 pA amplitude. (C–F) Comparison
of maximum diastolic potential (MDP), maximum upstroke velocity
[(dV/dt)max], action potential amplitude (APA) and action potential duration at
90% repolarization (APD90) of 9 hiPSC-CMs obtained with each of the three
IK1 models. Asterisks indicate statistically significant differences between IK1
models at each of the applied IK1 peak outward amplitudes.
at higher IK1 densities (Figure 9D). At first sight, this may suggest
a lower functional availability of fast sodium channels, despite
the longer time for recovery from inactivation at RMP in case
of the gain-of-function mutation as a result of the shortened
APD90 (Figure 9F). However, the somewhat lowered (dV/dt)max
may be due to the large gain-of-function IK1 that flows during the
upstroke (Figure 9B), especially at high IK1 densities, rather than
a lower functional availability of fast sodium channels.
In contrast, the injection of a loss-of-function IK1 has only
marginal effects, if any, on each of the action potential param-
eters, if compared to zero current injection (Figures 9C–F).
Spontaneous depolarization is not remarkably suppressed
throughout the range of IK1 densities, which is not surpris-
ing since the maximum peak outward amplitude is effectively 1
pA/pF because of the reduction to 10% of wild-type. Compared
to wild-type IK1 with a peak density >2 pA/pF, MDP is depo-
larized (Figure 9C), (dV/dt)max is diminished (Figure 9D) and
APA is considerably reduced (Figure 9E), whereas APD90 is
virtually unaffected (Figure 9F). Overall, the hiPSC-CM with-
out IK1 injection can be regarded as a model for severe
ATS1.
DISCUSSION
In the present study, we increased the expression level of IK1
in our hiPSC-CMs by adding in silico IK1 using a dynamic
patch clamp approach. First, we assessed the effects of the
type and magnitude of the added IK1. Three different mod-
els of IK1 were used, i.e., the “Kir2.1,” “TNNP,” and “Bett”
models, and the peak outward density of the inserted IK1
was varied between 1 and 10 pA/pF. Next, we assessed the
effects of both loss- and gain-of-function mutations in IK1 by
modifying our in silico IK1, thus simulating ATS1 and SQT3,
respectively.
CHARACTERISTICS OF hiPSC-CMs
Among our hiPSC-CMs, we observed both intrinsically quies-
cent and spontaneously beating cells (Figures 3B,C). However,
for the experiments in the present study, we selected sponta-
neously active hiPSC-CMs, because we expected those to exhibit
a smaller IK1 than the quiescent ones. We have no data regarding
the expression level of native IK1 in each individual hiPSC-CM
used in our dynamic clamp experiments, but our voltage clamp
experiments on the same type of cells demonstrate an almost
negligible IK1, which is even smaller than in the hiPSC-CMs
of Ma et al. (2011) and Doss et al. (2012). It should be kept
in mind that the selection of spontaneously beating cells for
our experiments may have led to the use of relatively immature
hiPSC-CMs.
With an MDP of −56 ± 4mV and an APA of 73 ± 9mV
(Figure 3D), our hiPSC-CMs exhibit a relatively depolarized
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FIGURE 9 | Effect of in silico mutations in Kir2.1 assessed with dynamic
clamp. (A) Control action potential of a hiPSC-CM (black trace) and action
potential of this cell upon injection of IK1 computed in real time according to
the “wild-type Kir2.1,” “loss-of-function,” or “gain-of-function” IK1 models of
Figure 2B (blue, magenta, and orange lines, respectively), all scaled by a
factor of 6, thus producing a wild-type IK1 peak outward amplitude of 6 pA/pF.
(B) Corresponding dynamic clamp current injected into the cell. The sharp
peak at time 25 ms is due to the stimulus current of 3 ms duration and 600
pA amplitude. (C–F) Comparison of maximum diastolic potential (MDP),
maximum upstroke velocity [(dV/dt)max], action potential amplitude (APA) and
action potential duration at 90% repolarization (APD90) of 6 hiPSC-CMs
obtained with each of the three IK1 models. Asterisks indicate statistically
significant differences between IK1 models at each of the applied wild-type
IK1 peak outward amplitudes.
MDP and low APA compared to those observed in other stud-
ies on hiPSC-CMs, as summarized in Table 1 of the review by
Hoekstra et al. (2012). The (dV/dt)max of 10 ± 7V/s is also
low, but that may reflect a low functional availability of sodium
channels due to the depolarized MDP, as does the relatively low
APA. Most striking, however, is the relatively short APD90 of
162 ± 27ms, similar to that of 173.5 ± 12.2ms (n = 16) in the
hiPSC-CMs of Davis et al. (2012), who selected quiescent rather
than spontaneously beating hiPSC-CMs for their action potential
recordings, but much shorter than that of 955 ± 103ms (n = 38)
and 967 ± 141ms (n = 30) in the spontaneously beating and
quiescent hiPSC-CMs, respectively, of Bett et al. (2013).
We have not made specific attempts to resolve the mecha-
nism underlying the spontaneous activity of our hiPSC-CMs.
In our voltage clamp experiments, there were no signs of a
functional hyperpolarization-activated “pacemaker current” or
“funny current” (If). This current had been observed in hiPSC-
CMs by Ma et al. (2011), which are the same type of cells that
Bett et al. (2013) used in their dynamic clamp study. However,
a strong reduction of IK1 is sufficient per se to generate spon-
taneous activity in VMs, as demonstrated by suppression of
IK1 through barium block in rabbit and guinea pig papillary
muscle (Antoni and Oberdisse, 1965; Aomine, 1989) and iso-
lated guinea pig VMs (Valenzuela and Vassalle, 1989), through
viral gene transfer in guinea pig VMs (Miake et al., 2003),
and in computer simulations (Doss et al., 2012; Nguyen et al.,
2013).
IK1 MODEL AND DYNAMIC CLAMP SETUP
The “Kir2.1” model of Dhamoon et al. (2004) is based on the
characteristics of inward rectifier current through Kir2.1 chan-
nels expressed in HEK-293 cells. The “TNNP” model stems from
the mathematical model of a human ventricular myocyte by ten
Tusscher et al. (2004), which is known as the TNNP model.
Whereas the I–V relationships of the Kir2.1 and TNNP models
are largely similar, the I–V relationship of the “Bett” model, which
is based on the “electronic expression” of IK1 in hiPSC-CMs by
Bett et al. (2013), is different, with a less pronounced rectifi-
cation (Figure 2A). A common feature of the three IK1 models
is the absence of any time dependence of IK1, which is in line
with the virtually instantaneous kinetics of IK1 in the membrane
potential range of the ventricular action potential (Dhamoon and
Jalife, 2005). It is, however, a straightforward operation to let the
dynamic clamp PC generate a time dependent IK1.
The setup of Figure 1, which is comparable to that of Bett
et al. (2013), is somewhat complicated. In daily practice, it would
be preferable to have the same computer both control the patch
clamp experiment and generate the in silico IK1 rather than
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having two computers perform these tasks and externally sum-
ming their command potentials. In case of a time independent
current like IK1, one may also use a dedicated patch clamp ampli-
fier, such as the Power1401 by Cambridge Electronic Design,
to realize the particular dynamic clamp configuration, which is
also known as “conductance injection,” “reactive current clamp,”
and “model reference current injection” (Wilders, 2006), and
was designated as “real-time current simulator” by Bett et al.
(2013).
MAGNITUDE AND RECTIFICATION OF IK1—WHICH MODEL TO USE?
Data from literature are far from unequivocal regarding the
magnitude and rectification of IK1 in mammalian VMs (see
Figure 4). Differences in recording conditions can only partly
explain the observed variety in experimental data. For example,
data acquired at room temperature (labeled “RT” in Figure 4)
rather than physiological temperature do not consistently show a
smaller IK1. Yet, from the reported Q10 of 1.5 ± 0.3 (mean ± SD,
n = 7; Kiyosue et al., 1993), one would expect an approximate
doubling of the magnitude of IK1 upon raising the temperature
from RT to physiological values. We refrained from “correcting”
the data in Figure 4 for temperature, which may have resulted
in an underestimation of the magnitude of IK1. A further, also
uncorrected underestimation may result from the determination
of IK1 as a barium dependent current (with widely different Ba2+
concentrations, ranging from 10μM to 1mM), because barium
block may be incomplete at the membrane potential of peak out-
ward IK1 (Bányász et al., 2007). Other issues, apart from technical
limitations, that may have had impact on the data in Figure 4,
are the dependence of IK1 magnitude on extracellular potassium
concentration, which is not identical in the listed papers, and
differences in corrections for liquid junction potential.
It is difficult to decide on a “physiological” value, or range of
values, for the peak outward amplitude of IK1. Nevertheless, from
the data in Figure 4B, an estimate of 2 pA/pF seems reasonable.
Interestingly, this is close to its value in several human ventricu-
lar cell models (Iyer et al., 2004; ten Tusscher et al., 2004; Grandi
et al., 2010). Another point of uncertainty is the degree of rectifi-
cation in the I–V relationship of IK1 (Figure 4A, inset), although
a less pronounced rectification in atrial vs. ventricular CMs is a
more or less consistent finding. This variable degree of rectifi-
cation, which seems attributable to different expression levels of
specific Kir2.x subunits (Wang et al., 1998), is why we tested qual-
itatively different I–V relationships. The Kir2.1 and TNNP I–V
relationships may be regarded as “ventricular-like,” whereas the I–
V relationship of the Bett IK1 is more “atrial-like,” although it was
intended by Bett et al. (2013) as an intermediate I–V relationship
that could be “optimized for cell specificity.”
From the data in Figures 5–7, we conclude that an outward
peak current density of 4–6 pA/pF is required to establish a stable
RMP near -80mV, associated with a (dV/dt)max of 160–170V/s
and an APA of 120mV, independent of the IK1 model used. Also,
around 6 pA/pF, the hiPSC-CM + IK1 model system studied
does not seem to be sensitive in its action potential parameters.
Interestingly, these action potential parameter values are compa-
rable to those of human VMs (Figure 3D), although it should be
kept in mind that the data of Verkerk et al. (2005) were obtained
with VMs isolated from explanted hearts of patients suffering
from end-stage heart failure, which may have led to remodeling
of membrane currents and thereby to changes in action poten-
tial parameters. The less pronounced rectification of the Bett
IK1 results in typically shorter APD90 values than with the other
two IK1 models (≈145 vs. ≈170ms), as becomes apparent from
Figure 8. In either case, APD90 is considerably shorter than that
of native human VMs.
Bett et al. (2013) also noted that a stable RMP could be
obtained through “electronic expression” of IK1. It is, however,
difficult to directly compare their findings to ours, not only
because of the differences in recording conditions (physiologi-
cal vs. room temperature, perforated vs. whole cell patch clamp),
but also because Bett et al. (2013) did not vary the magnitude of
their electronically expressed IK1. They used the same magnitude
of IK1 for all experiments because “this makes for simplicity in
application and aspects such as quickly distinguishing between
atrial and ventricular cells.” The potentiometer in their exper-
imental setup “was set to provide a standard outward current
of 150 pA at −75mV.” With their EK of −85mV, this translates
to a peak outward IK1 of 165 pA near −70mV. Unfortunately,
Bett et al. (2013) did not specify the membrane capacitance of
their cells, but an estimate can be made because they used the
commercially available iCell cardiomyocytes (Cellular Dynamics,
Madison, WI). According to Ma et al. (2011), these cells show a
capacitance of 35.0 ± 2.5 pF. If we assume that the hiPSC-CMs
used by Bett et al. (2013) had a similar capacitance, the peak
outward density of their IK1 amounts to ≈4.7 pA/pF (at room
temperature), which is within the aforementioned range of 4–6
pA/pF required to establish a stable RMP. In a total of 31 “stimu-
lated cells with artificial IK1,” Bett et al. (2013) observed an RMP
of −84 ± 0.1mV, an APA of 132 ± 2mV, and a (dV/dt)max of
147 ± 11V/s, which is comparable to our data. However, their
APD90, which can only be estimated from graphs, shows a wide
variety with typical values around 800ms and a maximum near
1800ms.
IK1 CHANNELOPATHIES
As long as hiPSC-CMs express a negligible IK1, it is impossible to
use hiPSC-CMs derived from ATS1 or SQT3 patients as a model
system to study both loss-of-function or gain-of-function muta-
tions in KCNJ2. It is, however, possible to study the effects of
such mutations in the setting of hiPSC-CMs through dynamic
clamp as we did in our experiments that are summarized in
Figure 9. In this way, we were able to demonstrate that the E299V
gain-of-function mutation causes a dramatic shortening of the
action potential (Figures 9A,F). This cellular observation is in
line with the clinically observed exceedingly short QT interval
with merging of the QRS complex and T wave (Deo et al., 2013).
As shown in Figure 9, simulation of a dominant-negative loss-
of-function mutation has only little effect on the intrinsic action
potential of our hiPSC-CMs. This suggests that the VMs of ATS1
patients exhibit an unstable and depolarized resting membrane
potential. This would result in a reduced functional availabil-
ity of fast sodium channels and thereby in a lengthening of the
QRS interval. However, this is not a common observation in
ATS1 patients. On the other hand, such QRS prolongation has
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been found in some but not all mouse models of ATS1 (Nguyen
et al., 2013). Hopefully, it will become possible to improve the
maturation process—thus “engineering adolescence” (Yang et al.,
2014)—and generate more mature hiPSC-CMs, with a clear
expression of IK1, that allow further research into this intriguing
issue.
APPLICATIONS OF VIRTUAL IK1
hiPSC-CMs are commonly seen as a promising model for the
cardiac research field. Spontaneously active hiPSC-CMs, or—less
commonly—intrinsically quiescent with a relatively depolarized
RMP, are frequently used in patch clamp studies on cardiac ion
channelopathies. However, the abnormal action potential profile,
and associated abnormal activation of specific membrane cur-
rents, may make the hiPSC-CM an untrustworthy model for the
study of certain ion channelopathies. In particular, as for exam-
ple noted by Davis et al. (2012), hiPSC-CMs studies on mutations
in the fast sodium channel should be interpreted with care. The
aim of the present study was to investigate the feasibility of inject-
ing the missing IK1 through dynamic clamp and thus make the
hiPSC-CM exhibit a more native ventricular cardiomyocyte-like
action potential.
Our study shows that it is feasible to let spontaneously beating
hiPSC-CMs exhibit a ventricular-like action potential with a near-
physiological resting membrane potential, maximum upstroke
velocity and action potential amplitude through the injection of
an in silico IK1 with a peak outward density of 4–6 pA/pF. The
simulated degree of rectification does primarily affect the action
potential duration. We suggest the use of the Kir2.1 model for IK1
with a peak outward density near 5 pA/pF. One may prefer the
addition of a linear component—as in the Bett model, but with
as substantially smaller amplitude (e.g., an amplitude at 0mV of
10–20% of peak outward amplitude)—to simulate a less strong
rectification, but this is not highly pertinent. As long as research
into improving the expression of IK1 in hiPSC-CMs is going on, it
may be helpful to improve their action potential profile bymaking
them express a virtual IK1 through dynamic clamp.
In conclusion, we can state that injection of in silico IK1
makes the hiPSC-CM a more reliable model for investigating
mechanisms underlying cardiac arrhythmias.
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